GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Tfdp1
|
ENSMUSG00000038482.10 | transcription factor Dp 1 |
Wt1
|
ENSMUSG00000016458.7 | Wilms tumor 1 homolog |
Egr2
|
ENSMUSG00000037868.9 | early growth response 2 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Tfdp1 | mm10_v2_chr8_+_13339656_13339674 | 0.89 | 5.3e-13 | Click! |
Wt1 | mm10_v2_chr2_+_105126505_105126529 | 0.76 | 9.7e-08 | Click! |
Egr2 | mm10_v2_chr10_+_67535493_67535583 | 0.56 | 3.6e-04 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr7_-_142657466 | 42.78 |
ENSMUST00000097936.2
ENSMUST00000000033.5 |
Igf2
|
insulin-like growth factor 2 |
chr7_-_142659482 | 32.37 |
ENSMUST00000121128.1
|
Igf2
|
insulin-like growth factor 2 |
chr11_-_12037391 | 26.07 |
ENSMUST00000093321.5
|
Grb10
|
growth factor receptor bound protein 10 |
chr12_-_76709997 | 25.63 |
ENSMUST00000166101.1
|
Sptb
|
spectrin beta, erythrocytic |
chr2_-_156839790 | 24.85 |
ENSMUST00000134838.1
ENSMUST00000137463.1 ENSMUST00000149275.2 |
Gm14230
|
predicted gene 14230 |
chr7_-_143460989 | 24.44 |
ENSMUST00000167912.1
ENSMUST00000037287.6 |
Cdkn1c
|
cyclin-dependent kinase inhibitor 1C (P57) |
chr11_+_95010277 | 22.87 |
ENSMUST00000124735.1
|
Samd14
|
sterile alpha motif domain containing 14 |
chr7_-_38107490 | 21.58 |
ENSMUST00000108023.3
|
Ccne1
|
cyclin E1 |
chr8_+_22974844 | 20.63 |
ENSMUST00000110688.2
ENSMUST00000121802.2 |
Ank1
|
ankyrin 1, erythroid |
chr12_+_109453455 | 20.18 |
ENSMUST00000109844.4
ENSMUST00000109842.2 ENSMUST00000109843.1 ENSMUST00000109846.4 ENSMUST00000173539.1 ENSMUST00000109841.2 |
Dlk1
|
delta-like 1 homolog (Drosophila) |
chr9_+_65101453 | 19.99 |
ENSMUST00000077696.6
ENSMUST00000035499.4 ENSMUST00000166273.1 |
Igdcc4
|
immunoglobulin superfamily, DCC subclass, member 4 |
chrX_-_73659724 | 19.33 |
ENSMUST00000114473.1
ENSMUST00000002087.7 |
Pnck
|
pregnancy upregulated non-ubiquitously expressed CaM kinase |
chr4_-_3938354 | 19.06 |
ENSMUST00000003369.3
|
Plag1
|
pleiomorphic adenoma gene 1 |
chr19_-_24555819 | 18.60 |
ENSMUST00000112673.2
ENSMUST00000025800.8 |
Pip5k1b
|
phosphatidylinositol-4-phosphate 5-kinase, type 1 beta |
chr2_+_163054682 | 18.20 |
ENSMUST00000018005.3
|
Mybl2
|
myeloblastosis oncogene-like 2 |
chr14_-_79301623 | 18.09 |
ENSMUST00000022595.7
|
Rgcc
|
regulator of cell cycle |
chr17_-_26201328 | 17.79 |
ENSMUST00000025019.2
|
Arhgdig
|
Rho GDP dissociation inhibitor (GDI) gamma |
chrX_+_73639414 | 17.18 |
ENSMUST00000019701.8
|
Dusp9
|
dual specificity phosphatase 9 |
chr19_+_60755947 | 16.75 |
ENSMUST00000088237.4
|
Nanos1
|
nanos homolog 1 (Drosophila) |
chr11_+_24078022 | 16.36 |
ENSMUST00000000881.6
|
Bcl11a
|
B cell CLL/lymphoma 11A (zinc finger protein) |
chr7_+_117380937 | 15.61 |
ENSMUST00000032892.5
|
Xylt1
|
xylosyltransferase 1 |
chr12_+_24831583 | 15.60 |
ENSMUST00000110942.3
ENSMUST00000078902.6 |
Mboat2
|
membrane bound O-acyltransferase domain containing 2 |
chr7_-_142578139 | 15.40 |
ENSMUST00000136359.1
|
H19
|
H19 fetal liver mRNA |
chr9_-_44288535 | 15.26 |
ENSMUST00000161354.1
|
Abcg4
|
ATP-binding cassette, sub-family G (WHITE), member 4 |
chr11_-_116581446 | 15.08 |
ENSMUST00000082152.4
|
Ube2o
|
ubiquitin-conjugating enzyme E2O |
chr11_+_95009852 | 14.84 |
ENSMUST00000055947.3
|
Samd14
|
sterile alpha motif domain containing 14 |
chr4_+_11191726 | 14.51 |
ENSMUST00000029866.9
ENSMUST00000108324.3 |
Ccne2
|
cyclin E2 |
chr4_+_127169131 | 14.26 |
ENSMUST00000046659.7
|
Dlgap3
|
discs, large (Drosophila) homolog-associated protein 3 |
chr16_-_22163299 | 14.24 |
ENSMUST00000100052.4
|
Igf2bp2
|
insulin-like growth factor 2 mRNA binding protein 2 |
chr19_+_47178820 | 14.21 |
ENSMUST00000111808.3
|
Neurl1a
|
neuralized homolog 1A (Drosophila) |
chr18_-_58209926 | 14.04 |
ENSMUST00000025497.6
|
Fbn2
|
fibrillin 2 |
chr12_-_109068173 | 13.60 |
ENSMUST00000073156.7
|
Begain
|
brain-enriched guanylate kinase-associated |
chr2_+_156840077 | 13.52 |
ENSMUST00000081335.6
ENSMUST00000073352.3 |
Tgif2
|
TGFB-induced factor homeobox 2 |
chr17_-_26201363 | 13.35 |
ENSMUST00000121959.1
|
Arhgdig
|
Rho GDP dissociation inhibitor (GDI) gamma |
chr2_-_153529941 | 13.14 |
ENSMUST00000035346.7
|
8430427H17Rik
|
RIKEN cDNA 8430427H17 gene |
chr3_-_100489324 | 13.13 |
ENSMUST00000061455.8
|
Fam46c
|
family with sequence similarity 46, member C |
chr11_+_11685909 | 13.10 |
ENSMUST00000065433.5
|
Ikzf1
|
IKAROS family zinc finger 1 |
chrX_-_73660047 | 12.96 |
ENSMUST00000114472.1
|
Pnck
|
pregnancy upregulated non-ubiquitously expressed CaM kinase |
chr8_-_121907678 | 12.92 |
ENSMUST00000045557.9
|
Slc7a5
|
solute carrier family 7 (cationic amino acid transporter, y+ system), member 5 |
chr2_-_102451792 | 12.74 |
ENSMUST00000099678.3
|
Fjx1
|
four jointed box 1 (Drosophila) |
chr3_-_69044697 | 12.65 |
ENSMUST00000136512.1
ENSMUST00000143454.1 ENSMUST00000107802.1 |
Trim59
|
tripartite motif-containing 59 |
chr10_-_80577285 | 12.58 |
ENSMUST00000038558.8
|
Klf16
|
Kruppel-like factor 16 |
chr4_+_129985098 | 12.57 |
ENSMUST00000106017.1
ENSMUST00000121049.1 |
Bai2
|
brain-specific angiogenesis inhibitor 2 |
chr19_+_7268296 | 12.56 |
ENSMUST00000066646.4
|
Rcor2
|
REST corepressor 2 |
chr8_+_83997613 | 12.35 |
ENSMUST00000095228.3
|
Samd1
|
sterile alpha motif domain containing 1 |
chr11_-_12026732 | 12.23 |
ENSMUST00000143915.1
|
Grb10
|
growth factor receptor bound protein 10 |
chr2_-_163918683 | 12.19 |
ENSMUST00000044734.2
|
Rims4
|
regulating synaptic membrane exocytosis 4 |
chr6_+_4747306 | 12.19 |
ENSMUST00000175823.1
ENSMUST00000176204.1 ENSMUST00000166678.1 |
Peg10
|
paternally expressed 10 |
chr17_-_25433775 | 12.09 |
ENSMUST00000159610.1
ENSMUST00000159048.1 ENSMUST00000078496.5 |
Cacna1h
|
calcium channel, voltage-dependent, T type, alpha 1H subunit |
chr8_-_123859423 | 12.06 |
ENSMUST00000034452.5
|
Ccsap
|
centriole, cilia and spindle associated protein |
chr5_+_137288273 | 11.96 |
ENSMUST00000024099.4
ENSMUST00000085934.3 |
Ache
|
acetylcholinesterase |
chr11_+_74619594 | 11.82 |
ENSMUST00000100866.2
|
E130309D14Rik
|
RIKEN cDNA E130309D14 gene |
chr11_-_94474088 | 11.57 |
ENSMUST00000107786.1
ENSMUST00000107791.1 ENSMUST00000103166.2 ENSMUST00000107792.1 ENSMUST00000100561.3 ENSMUST00000107793.1 ENSMUST00000107788.1 ENSMUST00000107790.1 ENSMUST00000107789.1 ENSMUST00000107785.1 ENSMUST00000021234.8 |
Cacna1g
|
calcium channel, voltage-dependent, T type, alpha 1G subunit |
chr11_+_62077018 | 11.53 |
ENSMUST00000092415.5
|
Specc1
|
sperm antigen with calponin homology and coiled-coil domains 1 |
chr3_+_68869563 | 11.53 |
ENSMUST00000054551.2
|
1110032F04Rik
|
RIKEN cDNA 1110032F04 gene |
chr15_+_78913916 | 11.51 |
ENSMUST00000089378.4
|
Pdxp
|
pyridoxal (pyridoxine, vitamin B6) phosphatase |
chr8_+_105518736 | 11.41 |
ENSMUST00000034363.5
|
Hsd11b2
|
hydroxysteroid 11-beta dehydrogenase 2 |
chr17_+_28801090 | 11.40 |
ENSMUST00000004985.9
|
Brpf3
|
bromodomain and PHD finger containing, 3 |
chr11_-_12026237 | 11.25 |
ENSMUST00000150972.1
|
Grb10
|
growth factor receptor bound protein 10 |
chr10_-_30803075 | 11.16 |
ENSMUST00000068567.4
|
Ncoa7
|
nuclear receptor coactivator 7 |
chr11_+_102604370 | 11.10 |
ENSMUST00000057893.5
|
Fzd2
|
frizzled homolog 2 (Drosophila) |
chr7_-_142578093 | 11.06 |
ENSMUST00000149974.1
ENSMUST00000152754.1 |
H19
|
H19 fetal liver mRNA |
chr2_-_180642681 | 10.96 |
ENSMUST00000037877.10
|
Tcfl5
|
transcription factor-like 5 (basic helix-loop-helix) |
chr1_-_193035651 | 10.92 |
ENSMUST00000016344.7
|
Syt14
|
synaptotagmin XIV |
chr10_+_82985473 | 10.72 |
ENSMUST00000040110.7
|
Chst11
|
carbohydrate sulfotransferase 11 |
chr16_+_17646464 | 10.67 |
ENSMUST00000056962.4
|
Ccdc74a
|
coiled-coil domain containing 74A |
chrX_-_52613936 | 10.61 |
ENSMUST00000114857.1
|
Gpc3
|
glypican 3 |
chr4_+_11191354 | 10.60 |
ENSMUST00000170901.1
|
Ccne2
|
cyclin E2 |
chr13_-_68999518 | 10.55 |
ENSMUST00000022013.7
|
Adcy2
|
adenylate cyclase 2 |
chr11_+_7063423 | 10.54 |
ENSMUST00000020706.4
|
Adcy1
|
adenylate cyclase 1 |
chr9_-_56635624 | 10.50 |
ENSMUST00000114256.1
|
Lingo1
|
leucine rich repeat and Ig domain containing 1 |
chrX_+_136270302 | 10.50 |
ENSMUST00000113112.1
|
Ngfrap1
|
nerve growth factor receptor (TNFRSF16) associated protein 1 |
chr8_+_93810832 | 10.46 |
ENSMUST00000034198.8
ENSMUST00000125716.1 |
Gnao1
|
guanine nucleotide binding protein, alpha O |
chr6_+_134929118 | 10.42 |
ENSMUST00000185152.1
ENSMUST00000184504.1 |
RP23-45G16.5
|
RP23-45G16.5 |
chr6_+_134929089 | 10.37 |
ENSMUST00000183867.1
ENSMUST00000184991.1 ENSMUST00000183905.1 |
RP23-45G16.5
|
RP23-45G16.5 |
chr16_+_18127607 | 10.35 |
ENSMUST00000059589.5
|
Rtn4r
|
reticulon 4 receptor |
chr12_+_110279228 | 10.33 |
ENSMUST00000097228.4
|
Dio3
|
deiodinase, iodothyronine type III |
chrX_-_136068236 | 10.22 |
ENSMUST00000049130.7
|
Bex2
|
brain expressed X-linked 2 |
chrX_-_52613913 | 10.16 |
ENSMUST00000069360.7
|
Gpc3
|
glypican 3 |
chr16_+_17646564 | 9.94 |
ENSMUST00000182117.1
ENSMUST00000182671.1 ENSMUST00000182344.1 |
Ccdc74a
|
coiled-coil domain containing 74A |
chr4_+_46450892 | 9.89 |
ENSMUST00000102926.4
|
Anp32b
|
acidic (leucine-rich) nuclear phosphoprotein 32 family, member B |
chr4_+_46039202 | 9.81 |
ENSMUST00000156200.1
|
Tmod1
|
tropomodulin 1 |
chr2_-_91931774 | 9.81 |
ENSMUST00000069423.6
|
Mdk
|
midkine |
chr2_+_103970115 | 9.81 |
ENSMUST00000111143.1
ENSMUST00000138815.1 |
Lmo2
|
LIM domain only 2 |
chr10_-_5805412 | 9.74 |
ENSMUST00000019907.7
|
Fbxo5
|
F-box protein 5 |
chr1_+_136131382 | 9.62 |
ENSMUST00000075164.4
|
Kif21b
|
kinesin family member 21B |
chr13_-_107022027 | 9.61 |
ENSMUST00000117539.1
ENSMUST00000122233.1 ENSMUST00000022204.9 ENSMUST00000159772.1 |
Kif2a
|
kinesin family member 2A |
chr2_-_152398046 | 9.61 |
ENSMUST00000063332.8
ENSMUST00000182625.1 |
Sox12
|
SRY-box containing gene 12 |
chr5_-_100159261 | 9.51 |
ENSMUST00000139520.1
|
Tmem150c
|
transmembrane protein 150C |
chr12_-_79007276 | 9.43 |
ENSMUST00000056660.6
ENSMUST00000174721.1 |
Tmem229b
|
transmembrane protein 229B |
chr2_+_145167706 | 9.43 |
ENSMUST00000110007.1
|
Slc24a3
|
solute carrier family 24 (sodium/potassium/calcium exchanger), member 3 |
chr12_-_112929415 | 9.42 |
ENSMUST00000075827.3
|
Jag2
|
jagged 2 |
chr13_+_48662989 | 9.29 |
ENSMUST00000021813.4
|
Barx1
|
BarH-like homeobox 1 |
chr7_-_134225088 | 9.25 |
ENSMUST00000067680.4
|
Adam12
|
a disintegrin and metallopeptidase domain 12 (meltrin alpha) |
chr11_+_3290300 | 9.18 |
ENSMUST00000057089.6
ENSMUST00000093402.5 |
Patz1
|
POZ (BTB) and AT hook containing zinc finger 1 |
chr5_+_141241490 | 9.17 |
ENSMUST00000085774.4
|
Sdk1
|
sidekick homolog 1 (chicken) |
chr2_+_118111876 | 9.10 |
ENSMUST00000039559.8
|
Thbs1
|
thrombospondin 1 |
chr2_+_127336152 | 9.09 |
ENSMUST00000028846.6
|
Dusp2
|
dual specificity phosphatase 2 |
chr1_-_182019927 | 9.09 |
ENSMUST00000078719.6
ENSMUST00000111030.3 ENSMUST00000177811.1 ENSMUST00000111024.3 ENSMUST00000111025.2 |
Enah
|
enabled homolog (Drosophila) |
chr7_+_27258725 | 9.06 |
ENSMUST00000079258.6
|
Numbl
|
numb-like |
chr11_+_103171081 | 9.03 |
ENSMUST00000042286.5
|
Fmnl1
|
formin-like 1 |
chr1_+_75382114 | 9.03 |
ENSMUST00000113590.1
ENSMUST00000148515.1 |
Speg
|
SPEG complex locus |
chr10_-_21160925 | 9.00 |
ENSMUST00000020158.6
|
Myb
|
myeloblastosis oncogene |
chrX_-_136215443 | 8.95 |
ENSMUST00000113120.1
ENSMUST00000113118.1 ENSMUST00000058125.8 |
Bex1
|
brain expressed gene 1 |
chr2_-_131562283 | 8.87 |
ENSMUST00000103184.3
|
Adra1d
|
adrenergic receptor, alpha 1d |
chr6_+_99692679 | 8.86 |
ENSMUST00000101122.1
|
Gpr27
|
G protein-coupled receptor 27 |
chr2_-_26021532 | 8.83 |
ENSMUST00000136750.1
|
Ubac1
|
ubiquitin associated domain containing 1 |
chr10_-_76961788 | 8.82 |
ENSMUST00000001148.4
ENSMUST00000105411.2 |
Pcbp3
|
poly(rC) binding protein 3 |
chr7_-_133123770 | 8.76 |
ENSMUST00000164896.1
ENSMUST00000171968.1 |
Ctbp2
|
C-terminal binding protein 2 |
chr7_-_120982260 | 8.75 |
ENSMUST00000033169.8
|
Cdr2
|
cerebellar degeneration-related 2 |
chr11_+_24080664 | 8.73 |
ENSMUST00000118955.1
|
Bcl11a
|
B cell CLL/lymphoma 11A (zinc finger protein) |
chr2_-_91931675 | 8.71 |
ENSMUST00000111309.1
|
Mdk
|
midkine |
chr5_-_52566264 | 8.67 |
ENSMUST00000039750.5
|
Lgi2
|
leucine-rich repeat LGI family, member 2 |
chr7_+_141061274 | 8.67 |
ENSMUST00000048002.5
|
B4galnt4
|
beta-1,4-N-acetyl-galactosaminyl transferase 4 |
chr4_+_115057683 | 8.66 |
ENSMUST00000161601.1
|
Tal1
|
T cell acute lymphocytic leukemia 1 |
chr17_-_56830916 | 8.64 |
ENSMUST00000002444.7
ENSMUST00000086801.5 |
Rfx2
|
regulatory factor X, 2 (influences HLA class II expression) |
chr5_+_99979061 | 8.62 |
ENSMUST00000046721.1
|
4930524J08Rik
|
RIKEN cDNA 4930524J08 gene |
chrX_+_8271133 | 8.58 |
ENSMUST00000127103.1
ENSMUST00000115591.1 |
Slc38a5
|
solute carrier family 38, member 5 |
chr19_+_6084983 | 8.53 |
ENSMUST00000025704.2
|
Cdca5
|
cell division cycle associated 5 |
chr9_-_57836706 | 8.53 |
ENSMUST00000164010.1
ENSMUST00000171444.1 ENSMUST00000098686.3 |
Arid3b
|
AT rich interactive domain 3B (BRIGHT-like) |
chr10_-_79874233 | 8.52 |
ENSMUST00000166023.1
ENSMUST00000167707.1 ENSMUST00000165601.1 |
BC005764
|
cDNA sequence BC005764 |
chr2_-_157079212 | 8.52 |
ENSMUST00000069098.6
|
Soga1
|
suppressor of glucose, autophagy associated 1 |
chr5_-_24351604 | 8.52 |
ENSMUST00000036092.7
|
Kcnh2
|
potassium voltage-gated channel, subfamily H (eag-related), member 2 |
chr16_-_18629864 | 8.49 |
ENSMUST00000096987.5
|
Sept5
|
septin 5 |
chr6_-_30958990 | 8.47 |
ENSMUST00000101589.3
|
Klf14
|
Kruppel-like factor 14 |
chr9_-_119578981 | 8.46 |
ENSMUST00000117911.1
ENSMUST00000120420.1 |
Scn5a
|
sodium channel, voltage-gated, type V, alpha |
chr11_+_24078173 | 8.44 |
ENSMUST00000109514.1
|
Bcl11a
|
B cell CLL/lymphoma 11A (zinc finger protein) |
chr10_-_19851459 | 8.42 |
ENSMUST00000059805.4
|
Slc35d3
|
solute carrier family 35, member D3 |
chr13_+_73467197 | 8.39 |
ENSMUST00000022099.8
|
Lpcat1
|
lysophosphatidylcholine acyltransferase 1 |
chr3_+_10012548 | 8.37 |
ENSMUST00000029046.8
|
Fabp5
|
fatty acid binding protein 5, epidermal |
chr11_-_96005872 | 8.35 |
ENSMUST00000013559.2
|
Igf2bp1
|
insulin-like growth factor 2 mRNA binding protein 1 |
chr15_+_80091320 | 8.33 |
ENSMUST00000009728.6
ENSMUST00000009727.5 |
Syngr1
|
synaptogyrin 1 |
chr5_-_140649018 | 8.30 |
ENSMUST00000042661.3
|
Ttyh3
|
tweety homolog 3 (Drosophila) |
chrX_-_7967817 | 8.29 |
ENSMUST00000033502.7
|
Gata1
|
GATA binding protein 1 |
chr10_-_116473875 | 8.24 |
ENSMUST00000068233.4
|
Kcnmb4
|
potassium large conductance calcium-activated channel, subfamily M, beta member 4 |
chr11_+_120949053 | 8.24 |
ENSMUST00000154187.1
ENSMUST00000100130.3 ENSMUST00000129473.1 ENSMUST00000168579.1 |
Slc16a3
|
solute carrier family 16 (monocarboxylic acid transporters), member 3 |
chr8_+_57511833 | 8.22 |
ENSMUST00000067925.6
|
Hmgb2
|
high mobility group box 2 |
chr4_-_88033328 | 8.21 |
ENSMUST00000078090.5
|
Mllt3
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 3 |
chr9_-_44234014 | 8.19 |
ENSMUST00000037644.6
|
Cbl
|
Casitas B-lineage lymphoma |
chr17_-_25727364 | 8.16 |
ENSMUST00000170070.1
ENSMUST00000048054.7 |
Chtf18
|
CTF18, chromosome transmission fidelity factor 18 |
chr7_-_133123160 | 8.14 |
ENSMUST00000166439.1
|
Ctbp2
|
C-terminal binding protein 2 |
chr2_-_33431324 | 8.07 |
ENSMUST00000113158.1
|
Zbtb34
|
zinc finger and BTB domain containing 34 |
chr11_-_69560186 | 8.07 |
ENSMUST00000004036.5
|
Efnb3
|
ephrin B3 |
chr4_-_133967235 | 8.05 |
ENSMUST00000123234.1
|
Hmgn2
|
high mobility group nucleosomal binding domain 2 |
chrX_+_159255919 | 8.02 |
ENSMUST00000112492.1
|
Rps6ka3
|
ribosomal protein S6 kinase polypeptide 3 |
chr2_-_153444441 | 8.02 |
ENSMUST00000109784.1
|
8430427H17Rik
|
RIKEN cDNA 8430427H17 gene |
chr4_-_152477433 | 8.01 |
ENSMUST00000159186.1
ENSMUST00000162017.1 ENSMUST00000030768.2 |
Kcnab2
|
potassium voltage-gated channel, shaker-related subfamily, beta member 2 |
chrX_+_8271642 | 7.90 |
ENSMUST00000115590.1
|
Slc38a5
|
solute carrier family 38, member 5 |
chr1_-_52232296 | 7.90 |
ENSMUST00000114512.1
|
Gls
|
glutaminase |
chr10_+_43579161 | 7.82 |
ENSMUST00000058714.8
|
Cd24a
|
CD24a antigen |
chr1_-_119053619 | 7.80 |
ENSMUST00000062483.8
|
Gli2
|
GLI-Kruppel family member GLI2 |
chr4_+_48585193 | 7.78 |
ENSMUST00000107703.1
|
Tmeff1
|
transmembrane protein with EGF-like and two follistatin-like domains 1 |
chr2_+_153492790 | 7.69 |
ENSMUST00000109783.1
|
4930404H24Rik
|
RIKEN cDNA 4930404H24 gene |
chr11_-_87359011 | 7.66 |
ENSMUST00000055438.4
|
Ppm1e
|
protein phosphatase 1E (PP2C domain containing) |
chr2_-_26021679 | 7.66 |
ENSMUST00000036509.7
|
Ubac1
|
ubiquitin associated domain containing 1 |
chr2_-_73775341 | 7.64 |
ENSMUST00000112024.3
ENSMUST00000166199.1 ENSMUST00000180045.1 |
Chn1
|
chimerin (chimaerin) 1 |
chr2_-_24763047 | 7.64 |
ENSMUST00000100348.3
ENSMUST00000041342.5 ENSMUST00000114447.1 ENSMUST00000102939.2 ENSMUST00000070864.7 |
Cacna1b
|
calcium channel, voltage-dependent, N type, alpha 1B subunit |
chr15_-_73184840 | 7.62 |
ENSMUST00000044113.10
|
Ago2
|
argonaute RISC catalytic subunit 2 |
chr6_-_38299236 | 7.62 |
ENSMUST00000058524.2
|
Zc3hav1l
|
zinc finger CCCH-type, antiviral 1-like |
chr11_+_53519871 | 7.60 |
ENSMUST00000120878.2
|
Sept8
|
septin 8 |
chr3_-_86920830 | 7.60 |
ENSMUST00000029719.8
|
Dclk2
|
doublecortin-like kinase 2 |
chr8_-_122551316 | 7.60 |
ENSMUST00000067252.7
|
Piezo1
|
piezo-type mechanosensitive ion channel component 1 |
chr4_+_115057410 | 7.57 |
ENSMUST00000136946.1
|
Tal1
|
T cell acute lymphocytic leukemia 1 |
chr11_+_35121126 | 7.54 |
ENSMUST00000069837.3
|
Slit3
|
slit homolog 3 (Drosophila) |
chr8_-_105637403 | 7.51 |
ENSMUST00000182046.1
|
Gm5914
|
predicted gene 5914 |
chr4_+_62965560 | 7.50 |
ENSMUST00000030043.6
ENSMUST00000107415.1 ENSMUST00000064814.5 |
Zfp618
|
zinc finger protein 618 |
chrX_-_142966709 | 7.49 |
ENSMUST00000041317.2
|
Ammecr1
|
Alport syndrome, mental retardation, midface hypoplasia and elliptocytosis chromosomal region gene 1 |
chr15_+_80173642 | 7.49 |
ENSMUST00000044970.6
|
Mgat3
|
mannoside acetylglucosaminyltransferase 3 |
chrX_+_160390684 | 7.47 |
ENSMUST00000112408.2
ENSMUST00000112402.1 ENSMUST00000112401.1 ENSMUST00000112400.1 ENSMUST00000112405.2 ENSMUST00000112404.2 ENSMUST00000146805.1 |
Gpr64
|
G protein-coupled receptor 64 |
chr12_+_5375870 | 7.46 |
ENSMUST00000037953.6
|
2810032G03Rik
|
RIKEN cDNA 2810032G03 gene |
chr4_+_129984833 | 7.42 |
ENSMUST00000120204.1
|
Bai2
|
brain-specific angiogenesis inhibitor 2 |
chr4_+_107802277 | 7.39 |
ENSMUST00000106733.2
ENSMUST00000030356.3 ENSMUST00000106732.2 ENSMUST00000126573.1 |
Lrp8
|
low density lipoprotein receptor-related protein 8, apolipoprotein e receptor |
chr4_-_133967893 | 7.39 |
ENSMUST00000100472.3
ENSMUST00000136327.1 |
Hmgn2
|
high mobility group nucleosomal binding domain 2 |
chr4_+_124700700 | 7.36 |
ENSMUST00000106199.3
ENSMUST00000038684.5 |
Fhl3
|
four and a half LIM domains 3 |
chr7_+_113513854 | 7.35 |
ENSMUST00000067929.8
ENSMUST00000129087.1 ENSMUST00000164745.1 ENSMUST00000136158.1 |
Far1
|
fatty acyl CoA reductase 1 |
chr3_+_88532314 | 7.34 |
ENSMUST00000172699.1
|
Mex3a
|
mex3 homolog A (C. elegans) |
chr17_-_46629420 | 7.33 |
ENSMUST00000044442.8
|
Ptk7
|
PTK7 protein tyrosine kinase 7 |
chr8_+_106168857 | 7.32 |
ENSMUST00000034378.3
|
Slc7a6
|
solute carrier family 7 (cationic amino acid transporter, y+ system), member 6 |
chr1_-_119053339 | 7.32 |
ENSMUST00000161301.1
ENSMUST00000161451.1 ENSMUST00000162607.1 |
Gli2
|
GLI-Kruppel family member GLI2 |
chrX_+_162760427 | 7.31 |
ENSMUST00000112326.1
|
Rbbp7
|
retinoblastoma binding protein 7 |
chr5_+_33820695 | 7.29 |
ENSMUST00000075812.4
ENSMUST00000114397.2 ENSMUST00000155880.1 |
Whsc1
|
Wolf-Hirschhorn syndrome candidate 1 (human) |
chr4_+_120666562 | 7.28 |
ENSMUST00000094814.4
|
Cited4
|
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 4 |
chr5_-_22344690 | 7.26 |
ENSMUST00000062372.7
ENSMUST00000161356.1 |
Reln
|
reelin |
chrX_+_20425688 | 7.23 |
ENSMUST00000115384.2
|
Phf16
|
PHD finger protein 16 |
chr11_-_120348475 | 7.23 |
ENSMUST00000062147.7
ENSMUST00000128055.1 |
Actg1
|
actin, gamma, cytoplasmic 1 |
chr7_+_99535652 | 7.22 |
ENSMUST00000032995.8
ENSMUST00000162404.1 |
Arrb1
|
arrestin, beta 1 |
chr1_-_184999549 | 7.18 |
ENSMUST00000027929.4
|
Mark1
|
MAP/microtubule affinity-regulating kinase 1 |
chr2_+_130295148 | 7.14 |
ENSMUST00000110288.2
|
Ebf4
|
early B cell factor 4 |
chr4_+_52439235 | 7.14 |
ENSMUST00000117280.1
ENSMUST00000102915.3 ENSMUST00000142227.1 |
Smc2
|
structural maintenance of chromosomes 2 |
chr13_+_117220584 | 7.13 |
ENSMUST00000022242.7
|
Emb
|
embigin |
chr8_-_80057989 | 7.11 |
ENSMUST00000079038.2
|
Hhip
|
Hedgehog-interacting protein |
chr11_+_53519725 | 7.10 |
ENSMUST00000108987.1
ENSMUST00000121334.1 ENSMUST00000117061.1 |
Sept8
|
septin 8 |
chr2_-_150668198 | 7.08 |
ENSMUST00000028944.3
|
Acss1
|
acyl-CoA synthetase short-chain family member 1 |
chr14_+_99298652 | 7.08 |
ENSMUST00000005279.6
|
Klf5
|
Kruppel-like factor 5 |
chr19_-_4615453 | 7.07 |
ENSMUST00000053597.2
|
Lrfn4
|
leucine rich repeat and fibronectin type III domain containing 4 |
chr12_-_27342696 | 7.05 |
ENSMUST00000079063.5
|
Sox11
|
SRY-box containing gene 11 |
chr7_+_19282613 | 7.05 |
ENSMUST00000032559.9
|
Rtn2
|
reticulon 2 (Z-band associated protein) |
chr15_+_39198244 | 7.01 |
ENSMUST00000082054.5
ENSMUST00000042917.9 |
Rims2
|
regulating synaptic membrane exocytosis 2 |
chr10_+_121033960 | 7.00 |
ENSMUST00000020439.4
ENSMUST00000175867.1 |
Wif1
|
Wnt inhibitory factor 1 |
chr5_+_37242025 | 7.00 |
ENSMUST00000114158.2
|
Crmp1
|
collapsin response mediator protein 1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
10.2 | 81.9 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
10.0 | 40.1 | GO:1904799 | regulation of neuron remodeling(GO:1904799) negative regulation of neuron remodeling(GO:1904800) |
6.4 | 19.2 | GO:0060217 | hemangioblast cell differentiation(GO:0060217) |
6.0 | 18.1 | GO:0003330 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
6.0 | 6.0 | GO:0060994 | regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
5.9 | 17.6 | GO:0045660 | positive regulation of neutrophil differentiation(GO:0045660) |
4.8 | 19.1 | GO:0060032 | notochord regression(GO:0060032) |
4.7 | 51.5 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
4.6 | 4.6 | GO:2000978 | negative regulation of forebrain neuron differentiation(GO:2000978) |
4.3 | 4.3 | GO:0030862 | positive regulation of polarized epithelial cell differentiation(GO:0030862) |
4.3 | 12.8 | GO:0034085 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
4.2 | 12.6 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
4.1 | 32.9 | GO:1902746 | regulation of lens fiber cell differentiation(GO:1902746) |
3.9 | 23.5 | GO:0003150 | muscular septum morphogenesis(GO:0003150) |
3.9 | 7.8 | GO:0015675 | nickel cation transport(GO:0015675) |
3.9 | 15.4 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
3.8 | 15.3 | GO:0086048 | membrane depolarization during bundle of His cell action potential(GO:0086048) |
3.8 | 11.4 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
3.8 | 15.0 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
3.6 | 25.3 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
3.5 | 17.6 | GO:0072138 | mesenchymal cell proliferation involved in ureteric bud development(GO:0072138) |
3.5 | 17.5 | GO:0071104 | response to interleukin-9(GO:0071104) |
3.5 | 24.3 | GO:0030421 | defecation(GO:0030421) |
3.5 | 3.5 | GO:0030860 | regulation of polarized epithelial cell differentiation(GO:0030860) |
3.4 | 10.3 | GO:0097021 | lymphocyte migration into lymphoid organs(GO:0097021) |
3.4 | 10.2 | GO:0060821 | inactivation of X chromosome by DNA methylation(GO:0060821) |
3.4 | 10.1 | GO:0030221 | basophil differentiation(GO:0030221) |
3.3 | 13.4 | GO:0051643 | endoplasmic reticulum localization(GO:0051643) |
3.3 | 13.2 | GO:1902303 | negative regulation of potassium ion export(GO:1902303) |
3.3 | 13.2 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
3.3 | 3.3 | GO:0051309 | female meiosis chromosome separation(GO:0051309) |
3.3 | 13.0 | GO:1902340 | telomeric heterochromatin assembly(GO:0031509) negative regulation of chromosome condensation(GO:1902340) |
3.1 | 12.5 | GO:0000415 | negative regulation of histone H3-K36 methylation(GO:0000415) |
3.1 | 18.7 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
3.1 | 9.3 | GO:0000915 | assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
3.0 | 9.1 | GO:1905000 | regulation of membrane repolarization during atrial cardiac muscle cell action potential(GO:1905000) |
3.0 | 9.1 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
3.0 | 15.2 | GO:0071692 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
3.0 | 9.1 | GO:0021849 | neuroblast division in subventricular zone(GO:0021849) |
3.0 | 9.1 | GO:0072382 | minus-end-directed vesicle transport along microtubule(GO:0072382) |
3.0 | 15.0 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
3.0 | 23.8 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
2.9 | 11.7 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
2.9 | 17.5 | GO:0072049 | comma-shaped body morphogenesis(GO:0072049) |
2.9 | 8.7 | GO:0090481 | pyrimidine nucleotide-sugar transmembrane transport(GO:0090481) |
2.9 | 8.7 | GO:0001983 | baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
2.9 | 8.6 | GO:0002270 | plasmacytoid dendritic cell activation(GO:0002270) |
2.8 | 2.8 | GO:0014809 | regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
2.8 | 13.9 | GO:0086045 | membrane depolarization during AV node cell action potential(GO:0086045) |
2.8 | 11.1 | GO:1904009 | response to monosodium glutamate(GO:1904008) cellular response to monosodium glutamate(GO:1904009) |
2.7 | 35.6 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
2.7 | 27.1 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
2.7 | 5.4 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
2.7 | 10.7 | GO:0006272 | leading strand elongation(GO:0006272) |
2.7 | 10.7 | GO:0086053 | AV node cell to bundle of His cell communication by electrical coupling(GO:0086053) |
2.6 | 7.9 | GO:0006226 | dUMP biosynthetic process(GO:0006226) |
2.6 | 10.5 | GO:1904776 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
2.6 | 10.5 | GO:0042822 | pyridoxal phosphate metabolic process(GO:0042822) |
2.6 | 2.6 | GO:0050923 | regulation of negative chemotaxis(GO:0050923) |
2.6 | 98.8 | GO:0006270 | DNA replication initiation(GO:0006270) |
2.6 | 2.6 | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
2.6 | 10.3 | GO:0007056 | spindle assembly involved in female meiosis(GO:0007056) |
2.6 | 15.4 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
2.6 | 7.7 | GO:0099526 | presynaptic signal transduction(GO:0098928) presynapse to nucleus signaling pathway(GO:0099526) |
2.5 | 12.6 | GO:0035989 | tendon development(GO:0035989) |
2.5 | 10.1 | GO:1904616 | regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
2.5 | 10.0 | GO:0010286 | heat acclimation(GO:0010286) |
2.4 | 4.9 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
2.4 | 12.1 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
2.4 | 4.8 | GO:0090579 | transcriptional activation by promoter-enhancer looping(GO:0071733) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
2.4 | 23.6 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
2.3 | 18.7 | GO:0010624 | regulation of Schwann cell proliferation(GO:0010624) |
2.3 | 6.8 | GO:2000620 | positive regulation of histone H4-K16 acetylation(GO:2000620) |
2.2 | 6.7 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
2.2 | 8.9 | GO:0035524 | proline transmembrane transport(GO:0035524) |
2.2 | 4.4 | GO:0010826 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
2.2 | 11.0 | GO:0097167 | circadian regulation of translation(GO:0097167) |
2.2 | 10.8 | GO:0008291 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
2.2 | 6.5 | GO:0098971 | anterograde dendritic transport of neurotransmitter receptor complex(GO:0098971) |
2.1 | 2.1 | GO:1901608 | regulation of vesicle transport along microtubule(GO:1901608) |
2.1 | 4.3 | GO:1904975 | response to bleomycin(GO:1904975) cellular response to bleomycin(GO:1904976) |
2.1 | 4.2 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
2.1 | 22.7 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
2.1 | 16.4 | GO:0061092 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
2.0 | 2.0 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
2.0 | 6.1 | GO:1904170 | regulation of bleb assembly(GO:1904170) |
2.0 | 8.1 | GO:0070829 | heterochromatin maintenance(GO:0070829) |
2.0 | 12.1 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
2.0 | 8.1 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
2.0 | 4.0 | GO:0060022 | hard palate development(GO:0060022) |
2.0 | 6.0 | GO:0050712 | negative regulation of interleukin-1 alpha production(GO:0032690) negative regulation of interleukin-1 alpha secretion(GO:0050712) |
2.0 | 6.0 | GO:0035585 | calcium-mediated signaling using extracellular calcium source(GO:0035585) |
2.0 | 7.9 | GO:1904049 | negative regulation of spontaneous neurotransmitter secretion(GO:1904049) |
2.0 | 2.0 | GO:0032241 | positive regulation of nucleobase-containing compound transport(GO:0032241) |
2.0 | 2.0 | GO:0046832 | negative regulation of nucleobase-containing compound transport(GO:0032240) negative regulation of RNA export from nucleus(GO:0046832) |
2.0 | 15.6 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
2.0 | 17.6 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
1.9 | 3.9 | GO:0060031 | mediolateral intercalation(GO:0060031) planar cell polarity pathway involved in gastrula mediolateral intercalation(GO:0060775) |
1.9 | 5.8 | GO:0099547 | regulation of translation at synapse, modulating synaptic transmission(GO:0099547) regulation of translation at postsynapse, modulating synaptic transmission(GO:0099578) positive regulation of intracellular transport of viral material(GO:1901254) |
1.9 | 11.4 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
1.9 | 5.6 | GO:1904209 | regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904207) positive regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904209) |
1.9 | 3.8 | GO:1904849 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
1.8 | 3.7 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
1.8 | 3.7 | GO:0090235 | regulation of metaphase plate congression(GO:0090235) |
1.8 | 1.8 | GO:1900110 | negative regulation of histone H3-K9 dimethylation(GO:1900110) |
1.8 | 9.1 | GO:1903527 | positive regulation of membrane tubulation(GO:1903527) |
1.8 | 18.1 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
1.8 | 14.3 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
1.8 | 7.1 | GO:0061386 | closure of optic fissure(GO:0061386) |
1.8 | 10.7 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
1.8 | 5.3 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) |
1.8 | 26.6 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
1.7 | 8.7 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
1.7 | 26.1 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
1.7 | 6.9 | GO:1904179 | positive regulation of adipose tissue development(GO:1904179) |
1.7 | 5.2 | GO:1901074 | regulation of engulfment of apoptotic cell(GO:1901074) |
1.7 | 8.6 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
1.7 | 10.3 | GO:0034441 | plasma lipoprotein particle oxidation(GO:0034441) |
1.7 | 12.0 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
1.7 | 8.6 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
1.7 | 6.8 | GO:0051590 | positive regulation of neurotransmitter secretion(GO:0001956) positive regulation of neurotransmitter transport(GO:0051590) |
1.7 | 5.1 | GO:2000872 | positive regulation of progesterone secretion(GO:2000872) |
1.7 | 5.1 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
1.7 | 11.8 | GO:0098535 | de novo centriole assembly(GO:0098535) |
1.7 | 3.3 | GO:0086098 | angiotensin-activated signaling pathway involved in heart process(GO:0086098) |
1.7 | 8.3 | GO:0044849 | estrous cycle(GO:0044849) |
1.7 | 8.3 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
1.6 | 14.8 | GO:0090267 | positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
1.6 | 9.9 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
1.6 | 9.8 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) |
1.6 | 4.8 | GO:0036353 | histone H2A-K119 monoubiquitination(GO:0036353) |
1.6 | 6.4 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
1.6 | 4.8 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
1.6 | 14.4 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
1.6 | 6.4 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
1.6 | 11.1 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
1.6 | 7.9 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
1.6 | 6.3 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
1.6 | 4.7 | GO:0014064 | positive regulation of serotonin secretion(GO:0014064) |
1.6 | 4.7 | GO:1901675 | negative regulation of histone H3-K27 acetylation(GO:1901675) |
1.5 | 7.7 | GO:0021993 | initiation of neural tube closure(GO:0021993) |
1.5 | 10.8 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
1.5 | 9.3 | GO:0033239 | negative regulation of cellular amine metabolic process(GO:0033239) |
1.5 | 1.5 | GO:0061511 | centriole elongation(GO:0061511) |
1.5 | 3.0 | GO:0000973 | posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
1.5 | 4.5 | GO:0035983 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
1.5 | 6.0 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
1.5 | 3.0 | GO:0045404 | interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
1.5 | 4.5 | GO:0060220 | camera-type eye photoreceptor cell fate commitment(GO:0060220) |
1.5 | 11.9 | GO:0019336 | phenol-containing compound catabolic process(GO:0019336) |
1.5 | 4.4 | GO:0090306 | spindle assembly involved in meiosis(GO:0090306) |
1.5 | 4.4 | GO:2001200 | positive regulation of dendritic cell differentiation(GO:2001200) |
1.5 | 4.4 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
1.4 | 21.7 | GO:0015816 | glycine transport(GO:0015816) |
1.4 | 13.0 | GO:0051571 | positive regulation of histone H3-K4 methylation(GO:0051571) |
1.4 | 10.0 | GO:0016185 | synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
1.4 | 10.0 | GO:0044806 | G-quadruplex DNA unwinding(GO:0044806) |
1.4 | 4.2 | GO:0042660 | positive regulation of cell fate specification(GO:0042660) |
1.4 | 5.7 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
1.4 | 5.7 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) |
1.4 | 25.4 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
1.4 | 8.4 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
1.4 | 4.2 | GO:0021592 | fourth ventricle development(GO:0021592) |
1.4 | 11.2 | GO:0034650 | cortisol metabolic process(GO:0034650) cortisol biosynthetic process(GO:0034651) |
1.4 | 4.2 | GO:1903438 | regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
1.4 | 4.2 | GO:0060364 | frontal suture morphogenesis(GO:0060364) |
1.4 | 5.5 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
1.4 | 2.8 | GO:0021558 | trochlear nerve development(GO:0021558) |
1.4 | 5.5 | GO:0007412 | axon target recognition(GO:0007412) |
1.4 | 4.1 | GO:0018008 | N-terminal peptidyl-glycine N-myristoylation(GO:0018008) |
1.4 | 2.7 | GO:0050705 | regulation of interleukin-1 alpha secretion(GO:0050705) positive regulation of interleukin-1 alpha secretion(GO:0050717) |
1.4 | 1.4 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
1.4 | 9.5 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
1.3 | 1.3 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
1.3 | 9.4 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
1.3 | 6.7 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
1.3 | 9.3 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
1.3 | 5.3 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
1.3 | 4.0 | GO:1990523 | bone regeneration(GO:1990523) |
1.3 | 6.6 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) |
1.3 | 21.1 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
1.3 | 5.3 | GO:0021586 | pons maturation(GO:0021586) |
1.3 | 1.3 | GO:0034971 | histone H3-R17 methylation(GO:0034971) |
1.3 | 1.3 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
1.3 | 6.6 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
1.3 | 7.8 | GO:1901300 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) |
1.3 | 3.9 | GO:0071873 | response to norepinephrine(GO:0071873) |
1.3 | 2.6 | GO:0002215 | defense response to nematode(GO:0002215) |
1.3 | 3.9 | GO:0032916 | positive regulation of transforming growth factor beta3 production(GO:0032916) |
1.3 | 1.3 | GO:1904879 | positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
1.3 | 5.2 | GO:0051582 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
1.3 | 3.9 | GO:0051754 | meiotic sister chromatid cohesion, centromeric(GO:0051754) |
1.3 | 7.7 | GO:0060120 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
1.3 | 10.2 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
1.3 | 2.5 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
1.3 | 3.8 | GO:1903367 | positive regulation of fear response(GO:1903367) positive regulation of behavioral fear response(GO:2000987) |
1.3 | 11.3 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
1.3 | 31.4 | GO:0040034 | regulation of development, heterochronic(GO:0040034) |
1.3 | 5.0 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
1.3 | 6.3 | GO:0038032 | termination of G-protein coupled receptor signaling pathway(GO:0038032) |
1.2 | 5.0 | GO:0015825 | L-serine transport(GO:0015825) |
1.2 | 7.5 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
1.2 | 54.8 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) |
1.2 | 9.9 | GO:1901673 | regulation of mitotic spindle assembly(GO:1901673) |
1.2 | 8.7 | GO:0033567 | DNA replication, Okazaki fragment processing(GO:0033567) |
1.2 | 23.2 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
1.2 | 1.2 | GO:1904023 | regulation of fermentation(GO:0043465) regulation of NAD metabolic process(GO:1902688) regulation of glucose catabolic process to lactate via pyruvate(GO:1904023) |
1.2 | 4.8 | GO:0040038 | polar body extrusion after meiotic divisions(GO:0040038) |
1.2 | 2.4 | GO:0000448 | cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000448) |
1.2 | 32.0 | GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) |
1.2 | 4.7 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
1.2 | 2.4 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
1.2 | 4.7 | GO:1903575 | cornified envelope assembly(GO:1903575) |
1.2 | 3.5 | GO:0071314 | cellular response to cocaine(GO:0071314) |
1.2 | 19.8 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
1.2 | 3.5 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
1.2 | 3.5 | GO:0051794 | regulation of catagen(GO:0051794) |
1.2 | 10.4 | GO:0046599 | regulation of centriole replication(GO:0046599) |
1.1 | 5.7 | GO:0002678 | positive regulation of chronic inflammatory response(GO:0002678) |
1.1 | 2.3 | GO:0071603 | endothelial cell-cell adhesion(GO:0071603) |
1.1 | 3.4 | GO:0042539 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
1.1 | 3.4 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
1.1 | 5.7 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
1.1 | 4.5 | GO:1904528 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) positive regulation of microtubule binding(GO:1904528) |
1.1 | 6.8 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
1.1 | 2.3 | GO:0033484 | nitric oxide homeostasis(GO:0033484) |
1.1 | 21.1 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
1.1 | 4.4 | GO:0010694 | positive regulation of alkaline phosphatase activity(GO:0010694) |
1.1 | 3.3 | GO:0046882 | negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
1.1 | 7.7 | GO:0099625 | ventricular cardiac muscle cell membrane repolarization(GO:0099625) |
1.1 | 12.1 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
1.1 | 4.4 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
1.1 | 3.3 | GO:2000568 | memory T cell activation(GO:0035709) regulation of memory T cell activation(GO:2000567) positive regulation of memory T cell activation(GO:2000568) |
1.1 | 30.6 | GO:0046852 | positive regulation of bone resorption(GO:0045780) positive regulation of bone remodeling(GO:0046852) |
1.1 | 10.9 | GO:0030859 | polarized epithelial cell differentiation(GO:0030859) |
1.1 | 1.1 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
1.1 | 3.3 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
1.1 | 3.3 | GO:0051892 | negative regulation of cardioblast differentiation(GO:0051892) |
1.1 | 1.1 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
1.1 | 7.6 | GO:0016266 | O-glycan processing(GO:0016266) |
1.1 | 8.6 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
1.1 | 2.1 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
1.1 | 4.3 | GO:1905077 | negative regulation of interleukin-17 secretion(GO:1905077) |
1.1 | 6.4 | GO:0007144 | female meiosis I(GO:0007144) |
1.1 | 15.0 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
1.1 | 5.4 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
1.1 | 44.8 | GO:1902850 | microtubule cytoskeleton organization involved in mitosis(GO:1902850) |
1.1 | 1.1 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
1.1 | 13.8 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
1.1 | 3.2 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
1.1 | 3.2 | GO:0099542 | trans-synaptic signaling by lipid(GO:0099541) trans-synaptic signaling by endocannabinoid(GO:0099542) |
1.1 | 7.4 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
1.1 | 12.7 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
1.1 | 6.3 | GO:0061669 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
1.1 | 6.3 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
1.1 | 4.2 | GO:1903288 | positive regulation of potassium ion import(GO:1903288) |
1.0 | 8.4 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
1.0 | 2.1 | GO:1901079 | positive regulation of relaxation of muscle(GO:1901079) |
1.0 | 3.1 | GO:0039532 | negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway(GO:0039532) |
1.0 | 4.1 | GO:0090521 | glomerular visceral epithelial cell migration(GO:0090521) |
1.0 | 3.1 | GO:0006592 | ornithine biosynthetic process(GO:0006592) |
1.0 | 2.1 | GO:0090649 | response to oxygen-glucose deprivation(GO:0090649) cellular response to oxygen-glucose deprivation(GO:0090650) |
1.0 | 6.2 | GO:2000465 | regulation of glycogen (starch) synthase activity(GO:2000465) |
1.0 | 7.2 | GO:0016198 | axon choice point recognition(GO:0016198) |
1.0 | 20.5 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
1.0 | 3.1 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
1.0 | 13.2 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
1.0 | 2.0 | GO:0043396 | corticotropin-releasing hormone secretion(GO:0043396) regulation of corticotropin-releasing hormone secretion(GO:0043397) positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
1.0 | 4.0 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
1.0 | 5.1 | GO:0035617 | stress granule disassembly(GO:0035617) |
1.0 | 3.0 | GO:0040030 | regulation of molecular function, epigenetic(GO:0040030) |
1.0 | 4.0 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
1.0 | 6.0 | GO:0035625 | receptor transactivation(GO:0035624) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
1.0 | 3.0 | GO:0060435 | bronchiole development(GO:0060435) |
1.0 | 5.0 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
1.0 | 3.0 | GO:0031133 | regulation of axon diameter(GO:0031133) |
1.0 | 1.0 | GO:1904580 | regulation of intracellular mRNA localization(GO:1904580) |
1.0 | 3.0 | GO:0051542 | elastin biosynthetic process(GO:0051542) |
1.0 | 8.9 | GO:0002903 | negative regulation of B cell apoptotic process(GO:0002903) |
1.0 | 5.9 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
1.0 | 5.9 | GO:0090520 | sphingolipid mediated signaling pathway(GO:0090520) |
1.0 | 4.9 | GO:0007256 | activation of JNKK activity(GO:0007256) |
1.0 | 1.0 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
1.0 | 4.9 | GO:0038089 | positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
1.0 | 6.9 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
1.0 | 2.9 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
1.0 | 3.9 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
1.0 | 2.9 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
1.0 | 2.0 | GO:0033058 | directional locomotion(GO:0033058) |
1.0 | 2.9 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
1.0 | 21.4 | GO:2000300 | regulation of synaptic vesicle exocytosis(GO:2000300) |
1.0 | 2.9 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
1.0 | 2.9 | GO:0032053 | ciliary basal body organization(GO:0032053) |
1.0 | 4.8 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
1.0 | 2.9 | GO:0051316 | attachment of spindle microtubules to kinetochore involved in meiotic chromosome segregation(GO:0051316) |
1.0 | 1.0 | GO:0086068 | Purkinje myocyte to ventricular cardiac muscle cell signaling(GO:0086029) Purkinje myocyte to ventricular cardiac muscle cell communication(GO:0086068) |
1.0 | 1.0 | GO:0097296 | activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) |
0.9 | 10.4 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.9 | 10.4 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
0.9 | 2.8 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.9 | 1.9 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
0.9 | 8.4 | GO:2000169 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
0.9 | 1.9 | GO:0046013 | regulation of T cell homeostatic proliferation(GO:0046013) |
0.9 | 5.6 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
0.9 | 2.8 | GO:1903244 | positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
0.9 | 2.8 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
0.9 | 2.8 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.9 | 0.9 | GO:0033128 | negative regulation of histone phosphorylation(GO:0033128) |
0.9 | 2.8 | GO:2000170 | positive regulation of peptidyl-cysteine S-nitrosylation(GO:2000170) |
0.9 | 7.3 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.9 | 35.6 | GO:0006284 | base-excision repair(GO:0006284) |
0.9 | 2.7 | GO:0072720 | response to dithiothreitol(GO:0072720) |
0.9 | 19.0 | GO:0051298 | centrosome duplication(GO:0051298) |
0.9 | 3.6 | GO:0061743 | motor learning(GO:0061743) |
0.9 | 4.5 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.9 | 0.9 | GO:0006677 | glycosylceramide metabolic process(GO:0006677) |
0.9 | 2.7 | GO:1902396 | protein localization to bicellular tight junction(GO:1902396) |
0.9 | 1.8 | GO:0072104 | renal system vasculature morphogenesis(GO:0061438) kidney vasculature morphogenesis(GO:0061439) glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) |
0.9 | 0.9 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.9 | 8.0 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.9 | 6.2 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.9 | 9.7 | GO:0002536 | respiratory burst involved in inflammatory response(GO:0002536) |
0.9 | 1.8 | GO:0055014 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
0.9 | 5.3 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
0.9 | 2.6 | GO:0002767 | immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
0.9 | 1.7 | GO:0034635 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
0.9 | 1.7 | GO:0014857 | skeletal muscle cell proliferation(GO:0014856) regulation of skeletal muscle cell proliferation(GO:0014857) |
0.9 | 2.6 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
0.9 | 17.4 | GO:1900151 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
0.9 | 8.6 | GO:0046476 | glycosylceramide biosynthetic process(GO:0046476) |
0.9 | 3.4 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.9 | 3.4 | GO:0046368 | GDP-L-fucose metabolic process(GO:0046368) |
0.9 | 12.0 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.9 | 6.9 | GO:0061072 | iris morphogenesis(GO:0061072) |
0.9 | 17.1 | GO:0001675 | acrosome assembly(GO:0001675) |
0.9 | 1.7 | GO:1902219 | negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.9 | 3.4 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.8 | 0.8 | GO:0061193 | taste bud development(GO:0061193) |
0.8 | 6.7 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.8 | 1.7 | GO:0002842 | positive regulation of T cell mediated immune response to tumor cell(GO:0002842) |
0.8 | 16.0 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.8 | 2.5 | GO:0001869 | regulation of complement activation, lectin pathway(GO:0001868) negative regulation of complement activation, lectin pathway(GO:0001869) |
0.8 | 17.6 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.8 | 2.5 | GO:0017055 | negative regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0017055) |
0.8 | 4.2 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.8 | 2.5 | GO:0071698 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.8 | 5.0 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
0.8 | 1.7 | GO:0032877 | positive regulation of DNA endoreduplication(GO:0032877) |
0.8 | 1.6 | GO:0038183 | bile acid signaling pathway(GO:0038183) |
0.8 | 4.1 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
0.8 | 4.1 | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
0.8 | 3.3 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.8 | 0.8 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.8 | 0.8 | GO:2000642 | negative regulation of early endosome to late endosome transport(GO:2000642) |
0.8 | 2.4 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.8 | 0.8 | GO:0032796 | uropod organization(GO:0032796) |
0.8 | 12.0 | GO:0033260 | nuclear DNA replication(GO:0033260) |
0.8 | 6.4 | GO:0015074 | DNA integration(GO:0015074) |
0.8 | 0.8 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.8 | 2.4 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.8 | 2.4 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
0.8 | 3.9 | GO:0035063 | nuclear speck organization(GO:0035063) |
0.8 | 0.8 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
0.8 | 4.7 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.8 | 3.1 | GO:0002540 | leukotriene production involved in inflammatory response(GO:0002540) |
0.8 | 1.6 | GO:1902661 | regulation of glucose mediated signaling pathway(GO:1902659) positive regulation of glucose mediated signaling pathway(GO:1902661) |
0.8 | 3.1 | GO:0060437 | lung growth(GO:0060437) |
0.8 | 3.9 | GO:1901563 | response to camptothecin(GO:1901563) |
0.8 | 4.7 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
0.8 | 5.4 | GO:0032532 | regulation of microvillus length(GO:0032532) |
0.8 | 0.8 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
0.8 | 1.5 | GO:1901994 | negative regulation of meiotic cell cycle phase transition(GO:1901994) |
0.8 | 10.7 | GO:0051451 | myoblast migration(GO:0051451) |
0.8 | 3.1 | GO:0003349 | epicardium-derived cardiac endothelial cell differentiation(GO:0003349) |
0.8 | 24.5 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) |
0.8 | 0.8 | GO:0010536 | positive regulation of activation of Janus kinase activity(GO:0010536) |
0.8 | 7.6 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
0.8 | 11.5 | GO:0007614 | short-term memory(GO:0007614) |
0.8 | 3.8 | GO:0071435 | potassium ion export(GO:0071435) |
0.8 | 3.0 | GO:1904566 | response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
0.8 | 0.8 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.8 | 3.0 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.8 | 3.8 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.8 | 12.2 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.8 | 3.0 | GO:0046381 | CMP-N-acetylneuraminate metabolic process(GO:0046381) |
0.8 | 1.5 | GO:0060722 | spongiotrophoblast cell proliferation(GO:0060720) cell proliferation involved in embryonic placenta development(GO:0060722) |
0.8 | 0.8 | GO:0006407 | rRNA export from nucleus(GO:0006407) |
0.8 | 0.8 | GO:0003162 | atrioventricular node development(GO:0003162) |
0.8 | 4.5 | GO:0061641 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.7 | 3.0 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.7 | 3.0 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
0.7 | 2.2 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.7 | 2.2 | GO:0090191 | negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
0.7 | 4.5 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.7 | 1.5 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
0.7 | 3.0 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.7 | 1.5 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
0.7 | 4.4 | GO:1903755 | regulation of SUMO transferase activity(GO:1903182) positive regulation of SUMO transferase activity(GO:1903755) |
0.7 | 2.2 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.7 | 2.2 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
0.7 | 22.0 | GO:0051225 | spindle assembly(GO:0051225) |
0.7 | 2.2 | GO:1904504 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
0.7 | 1.4 | GO:0036090 | cleavage furrow ingression(GO:0036090) |
0.7 | 4.3 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.7 | 5.0 | GO:0007296 | vitellogenesis(GO:0007296) |
0.7 | 23.6 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.7 | 1.4 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.7 | 1.4 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.7 | 2.8 | GO:0060023 | soft palate development(GO:0060023) |
0.7 | 0.7 | GO:0031990 | mRNA export from nucleus in response to heat stress(GO:0031990) |
0.7 | 7.0 | GO:1902547 | regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902547) |
0.7 | 1.4 | GO:0021506 | anterior neuropore closure(GO:0021506) neuropore closure(GO:0021995) |
0.7 | 1.4 | GO:2000172 | regulation of branching morphogenesis of a nerve(GO:2000172) |
0.7 | 10.4 | GO:0007413 | axonal fasciculation(GO:0007413) |
0.7 | 2.1 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
0.7 | 15.8 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.7 | 3.4 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) |
0.7 | 2.0 | GO:0060912 | central nervous system myelin formation(GO:0032289) cardiac cell fate specification(GO:0060912) |
0.7 | 3.4 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.7 | 3.4 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.7 | 4.0 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.7 | 8.7 | GO:0006999 | nuclear pore organization(GO:0006999) |
0.7 | 4.7 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.7 | 18.0 | GO:0034724 | DNA replication-independent nucleosome organization(GO:0034724) |
0.7 | 2.7 | GO:1902033 | regulation of hematopoietic stem cell proliferation(GO:1902033) |
0.7 | 0.7 | GO:1902256 | apoptotic process involved in outflow tract morphogenesis(GO:0003275) regulation of apoptotic process involved in outflow tract morphogenesis(GO:1902256) |
0.7 | 2.0 | GO:0002644 | negative regulation of tolerance induction(GO:0002644) |
0.7 | 7.2 | GO:0051014 | actin filament severing(GO:0051014) |
0.7 | 1.3 | GO:1902915 | negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
0.7 | 2.0 | GO:0034473 | U1 snRNA 3'-end processing(GO:0034473) U5 snRNA 3'-end processing(GO:0034476) |
0.7 | 2.0 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
0.7 | 15.0 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.7 | 1.3 | GO:0070571 | negative regulation of neuron projection regeneration(GO:0070571) |
0.7 | 2.0 | GO:0048298 | positive regulation of isotype switching to IgA isotypes(GO:0048298) |
0.6 | 4.5 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.6 | 7.1 | GO:1901249 | regulation of lung goblet cell differentiation(GO:1901249) negative regulation of lung goblet cell differentiation(GO:1901250) |
0.6 | 8.4 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.6 | 3.2 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.6 | 0.6 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.6 | 2.6 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.6 | 0.6 | GO:2000969 | positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.6 | 1.9 | GO:0021691 | cerebellar Purkinje cell layer maturation(GO:0021691) |
0.6 | 3.8 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.6 | 0.6 | GO:0031335 | regulation of sulfur amino acid metabolic process(GO:0031335) |
0.6 | 2.5 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.6 | 1.9 | GO:1903378 | positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
0.6 | 5.6 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.6 | 6.9 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
0.6 | 1.2 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.6 | 2.5 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.6 | 8.1 | GO:0048368 | lateral mesoderm development(GO:0048368) |
0.6 | 1.9 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.6 | 4.9 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.6 | 5.6 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.6 | 1.2 | GO:0036292 | DNA rewinding(GO:0036292) |
0.6 | 3.1 | GO:0051697 | protein delipidation(GO:0051697) |
0.6 | 5.5 | GO:0061085 | regulation of histone H3-K27 methylation(GO:0061085) |
0.6 | 0.6 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
0.6 | 1.8 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.6 | 7.9 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.6 | 1.8 | GO:0098884 | postsynaptic neurotransmitter receptor internalization(GO:0098884) regulation of endosome organization(GO:1904978) positive regulation of endosome organization(GO:1904980) |
0.6 | 4.8 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
0.6 | 1.8 | GO:0097309 | cap1 mRNA methylation(GO:0097309) |
0.6 | 2.4 | GO:0030576 | Cajal body organization(GO:0030576) |
0.6 | 1.2 | GO:0048818 | positive regulation of hair follicle maturation(GO:0048818) positive regulation of anagen(GO:0051885) |
0.6 | 1.2 | GO:0060982 | coronary artery morphogenesis(GO:0060982) |
0.6 | 1.2 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.6 | 3.6 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.6 | 10.1 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.6 | 2.4 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.6 | 1.2 | GO:0021776 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
0.6 | 2.3 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.6 | 5.8 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
0.6 | 12.8 | GO:0010842 | retina layer formation(GO:0010842) |
0.6 | 3.5 | GO:0090070 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
0.6 | 3.5 | GO:0045585 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
0.6 | 11.0 | GO:0015804 | neutral amino acid transport(GO:0015804) |
0.6 | 8.6 | GO:0045005 | DNA-dependent DNA replication maintenance of fidelity(GO:0045005) |
0.6 | 8.5 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.6 | 2.8 | GO:0003100 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
0.6 | 4.0 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
0.6 | 2.3 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.6 | 1.7 | GO:0048254 | snoRNA localization(GO:0048254) |
0.6 | 2.2 | GO:1904425 | negative regulation of GTP binding(GO:1904425) |
0.6 | 2.2 | GO:0044565 | dendritic cell proliferation(GO:0044565) |
0.6 | 10.1 | GO:0071392 | cellular response to estradiol stimulus(GO:0071392) |
0.6 | 2.2 | GO:0035799 | ureter maturation(GO:0035799) |
0.6 | 2.2 | GO:0061339 | establishment of monopolar cell polarity(GO:0061162) establishment or maintenance of monopolar cell polarity(GO:0061339) |
0.6 | 1.1 | GO:0060463 | lung lobe development(GO:0060462) lung lobe morphogenesis(GO:0060463) |
0.6 | 1.7 | GO:0006713 | glucocorticoid catabolic process(GO:0006713) |
0.6 | 0.6 | GO:0042339 | keratan sulfate metabolic process(GO:0042339) |
0.5 | 2.7 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
0.5 | 1.1 | GO:2000016 | negative regulation of determination of dorsal identity(GO:2000016) |
0.5 | 4.4 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
0.5 | 4.3 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.5 | 2.7 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.5 | 5.4 | GO:0043312 | neutrophil degranulation(GO:0043312) |
0.5 | 3.8 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.5 | 1.1 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.5 | 1.6 | GO:1902310 | positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
0.5 | 0.5 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.5 | 5.3 | GO:0032060 | bleb assembly(GO:0032060) |
0.5 | 1.1 | GO:1990918 | double-strand break repair involved in meiotic recombination(GO:1990918) |
0.5 | 0.5 | GO:0033121 | regulation of purine nucleotide catabolic process(GO:0033121) negative regulation of purine nucleotide catabolic process(GO:0033122) |
0.5 | 0.5 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.5 | 1.1 | GO:1904245 | regulation of polynucleotide adenylyltransferase activity(GO:1904245) |
0.5 | 2.1 | GO:0071043 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.5 | 9.0 |